Debra Wood, RN
Cerebral palsy (CP) is a group of chronic disorders that affect the ability to control movement. It appears in the first few years of life. Generally, the disorders do not worsen over time.
CP occurs due to damage to areas of the brain that direct movement. This damage interferes with the brain's ability to control movement and posture. CP may develop before, during, or after birth.
Factors that increase the risk of CP include:
Symptoms of CP vary widely. They may include difficulty with fine motor tasks like writing or using scissors difficulty maintaining balance or walking, and involuntary movements. The symptoms differ from person to person and may change over time.
CP first shows up in children aged three years or younger. Symptoms vary depending on what areas of the brain are affected. Some children may have severe disabilities. Although symptoms may change as the child grows older, the child's condition is unlikely to worsen.
Some people with CP suffer from other medical disorders as well, including:
Doctors diagnose CP by testing motor skills and reflexes, looking into medical history, and using a variety of specialized tests.
There is no treatment to cure CP. The brain damage cannot be corrected. Therapy aims to help the child reach his or her full potential. Children with CP grow to adulthood and may be able to work and live independently.
Drugs help control muscle spasms and seizures.
Certain operations may improve the ability to sit, stand, and walk.
Braces and splints help keep limbs in correct alignment and prevent deformities. Positioning devices enable better posture.
, special scooters, and
make it easier to move around.
Programs designed to meet the child's special needs may improve learning. Some children do well attending regular schools with special services. Vocational training can help prepare young adults for jobs.
Speech, physical, and occupational therapies may improve the ability to speak, move, walk, and perform activities of daily living. Physical therapy helps strengthen muscles. Children can learn different ways to complete difficult tasks.
Professional support helps a patient and family cope with CP.
help parents learn how to modify behaviors. Caring for a child with CP can be stressful. Some families find
Therapeutic electrical stimulation might help.
Several of the causes of CP that have been identified through research are preventable or treatable:
United Cerebral Palsy
The Cerebral Palsy Association of BC
Ontario Federation for Cerebral Palsy
Ashwal S, Russman BS, Blasco PA, et al. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Cerebral palsy. EBSCO DynaMed website. Available at:
https://dynamed.ebscohost.com/about/about-us. Updated December 14, 2012. Accessed February 1, 2013.
Cerebral palsy (CP).
Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities website. Available at:
http://www.cdc.gov/ncbddd/cp/index.html. Updated September 7, 2012. Accessed February 1, 2013.
Cerebral palsy: hope through research. National Institute of Neurological Disorders and Stroke website. Available at:
http://www.ninds.nih.gov/disorders/cerebral_palsy/detail_cerebral_palsy.htm. Updated August 23, 2012. Accessed February 1, 2013.
Hazneci B, Tan AK, Guncikan MN, Dincer K, Kalyon TA.
Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial.
Mil Med. 2006;171(7):653-656.
Johnson SL, Blair E, Stanley FJ. Obstetric malpractice litigation and cerebral palsy in term infants.
J Forensic Leg Med. 2011;18(3):97-100.
Nolan KW, Cole LL, Liptak GS. Use of botulinum toxin type A in children with cerebral palsy.
Phys Ther. 2006;86(4):573-584.
Park ES, Park CI, Chang HC, Park CW, Lee DS.
The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
Clin Rehabil. 2006;20(8):668-674.
Steinbok P. Selection of treatment modalities in children with spastic cerebral palsy.
Neurosurg Focus. 2006;21(2):e4.
10/30/2009 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: Mergler S, Evenhuis HM, Boot AM, et al. Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review.
Dev Med Child Neurol. 2009;51(10):773-778.
2/4/2010 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: Delgado MR, Hirtz D, Aisen M, et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
7/30/2010 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us: United States Food and Drug Administration. FDA approves drug for chronic drooling in children. United States Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm220444.htm. Published July 28, 2010. Accessed July 30, 2010.
Last reviewed September 2013 by Kari Kassir, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.